90 filings
EFFECT
ABOS
Acumen Pharmaceuticals Inc
25 Apr 24
Notice of effectiveness
12:15am
ARS
2023 FY
ABOS
Acumen Pharmaceuticals Inc
22 Apr 24
Annual report to shareholders
4:33pm
DEFA14A
ABOS
Acumen Pharmaceuticals Inc
22 Apr 24
Additional proxy soliciting materials
4:31pm
DEF 14A
ABOS
Acumen Pharmaceuticals Inc
Definitive proxy
22 Apr 24
4:30pm
S-3
ABOS
Acumen Pharmaceuticals Inc
Shelf registration
27 Mar 24
4:34pm
S-8
zdco1p3rud
27 Mar 24
Registration of securities for employees
4:02pm
8-K
dafk106bxf0bodh2lif
26 Mar 24
Results of Operations and Financial Condition
7:42am
8-K
4hq ukqnqhd5s98gfxtw
19 Mar 24
Corporate Presentation March 2024 1
8:05am
8-K
gev4hzgmf44l9qe1fgm
1 Feb 24
Departure of Directors or Certain Officers
7:16am
8-K
aql 2vkqmayw
12 Jan 24
Corporate Presentation January 2024 1
8:42am
8-K
dbuu470hc4 pphg1ue7
8 Jan 24
Regulation FD Disclosure
8:33am
8-K
ocj8je8xmff
4 Dec 23
Corporate Presentation December 2023 1
7:45am
8-K
lhnmb7vh7
13 Nov 23
Corporate Presentation November 2023 1
5:10pm
8-K
2wutx671obyw5ma3md51
13 Nov 23
Acumen Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Highlights
7:20am
8-K
m7h0tc59i
8 Nov 23
Entry into a Material Definitive Agreement
5:59pm
8-K
19aan8
8 Aug 23
Acumen Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business Highlights
7:33am
424B5
xepwb601
20 Jul 23
Prospectus supplement for primary offering
4:11pm